共 50 条
- [26] High Response Rate to Carboplatin-Paclitaxel-Cetuximab and Pembrolizumab in Patients with Recurrent and/or Metastatic Head and Neck Squamous Cell Carcinoma CASE REPORTS IN ONCOLOGY, 2023, 16 (01): : 13 - 20
- [29] METASTATIC BASAL-CELL CARCINOMA ANNALES DE DERMATOLOGIE ET DE VENEREOLOGIE, 1993, 120 (02): : 135 - 138